Type 1 Diabetes
7 videos · last 6 months shuffled daily, then older videos newest first
▶
1:03 QWINT-1: Once-Weekly Insulin Efsitora in Type 2 Diabetes
WeTrials summarises the Phase 3 QWINT-1 trial behind the FDA approval of once-weekly insulin efsitora for type 2 diabetes, in which 795 adults saw A1C fall by a similar amount to daily insulin glargine over 52 weeks.
▶
53:00 The Future of Diabetes Treatment: Beta Cell Regeneration
Michael G. King of Rodman & Renshaw talks to endocrinologist Dr. Alex Abitbol about beta cell regeneration and the evolving diabetes treatment landscape.
▶
52:06 The Latest Therapeutic Developments for Type 1 Diabetes Post-ADA
Piper Sandler analyst Ted Tenthoff and Joslin Diabetes Center's Dr. Rohit Kulkarni discuss type 1 diabetes data from ADA 2026, including teplizumab, beta cell regeneration and menin inhibition.
▶
6:19 Stanford Diabetes Research Center Employee Discusses How to Get Involved In Diabetes Clinical Research
Stanford University Diabetes Researcher discusses observational studies and interventional trials and why people should participate in clinical trials along with a link to a list of all of the Diabetes clinical trials at Stanford and description of how their online patient screener works.
▶
21:22 Lilla Lördag – Diamyd Medical
Ulf Hannelius, CEO of Diamyd Medical, on precision immunotherapies targeting the autoimmune process behind type 1 diabetes, and the Phase 3 trial of retogatein ahead of a March 2026 interim readout.
▶
3:27 Diabetes Research Institute on One Year Insulin-Free After an Islet Cell Transplant
Marlaina Goedel took part in a Diabetes Research Institute trial testing pancreatic islet cell transplants alongside anti-CD40 ligand, a newer anti-rejection drug. A year on she is living without insulin.
▶
1:48 Stem Cell Clinical Trials for Type 1 Diabetes Breakthrough
A clinical trial was funded by JDRF, a non profit involved in Type 1 Diabetes.